Cardiothoracic and Vascular Surgery
Management and Optimization of Hemostasis
Source: Br J Anaesth 2016;116(5):618-23.
Indexed: PubMed 26893405
Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery.
Source: Drugs R D 2015;15(2):187-94.
Indexed: PubMed 25862216
Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.
Source: J Am Heart Assoc 2015;4(6):e002066.
Indexed: PubMed 26037084
First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.
Source: Anesthesiology 2011;115(6):1179-1191.
Indexed: PubMed 21970887
Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial.
Source: Anesthesiology 2013;118(1):40-50.
Indexed: PubMed 23249928
Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
Source: Innovations (Phila) 2012;7(4):229-41.
Indexed: PubMed 23123988
Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation.
Source: Heart Lung Circ 2012;21(11):706-10.
Indexed: PubMed 22842057
Use of activated recombinant factor VII in severe bleeding—evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding.
Source: Transfus Med Hemother 2012;39(2):139-50.
Indexed: PubMed 22670132
Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products.
Source: Scand J Clin Lab Invest 2012;72(2):121-8.
Indexed: PubMed 22233480
Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate.
Source: Can J Anaesth 2012;59(3):299-303.
Indexed: PubMed 22161243
Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.
Source: Anesth Analg 2012;115(2):239-43.
Indexed: PubMed 21737704
Source: J Vasc Surg 2011;53(4):1032-7.
Indexed: PubMed 21215579
Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery.
Source: Circulation 2009;120(1):21-7.
Indexed: PubMed 19546387
Influence of body core temperature on blood loss and transfusion requirements during off-pump coronary artery bypass grafting: A comparison of 3 warming systems.
Source: J Thorac Cardiovasc Surg 2005;129(4):838-43.
Indexed: PubMed 15821652